Drug Science’s Project Twenty21 is a registry aiming to monitor the health outcomes of 20,000 patients using cannabis based medicinal products. It’s aim is to create the largest body of evidence in Europe for the safety and efficacy of medical cannabis.

The project gives access to medical cannabis for patients living with:

• Anxiety Disorder
• Chronic Pain
• Multiple Sclerosis (MS)
• Post-Traumatic Stress Disorder (PTSD)
• Substance Use Disorder (as a harm reduction strategy)
• Tourette’s Syndrome

Visit www.drugscience.org.uk for the latest information about Project Twenty21.

Prescribing as part of Twenty21

Clinician specialising in one of the seven indications listed here who and would like to find out more about prescribing medical cannabis should email [email protected] for more information.